It all started with a profound discovery:

The CB-SC Stem Cell

In 2005, Dr. Yong Zhao discovered and patented a new type of stem cell from the human umbilical-cord blood called CB-SC. These ethically derived stem cells are more powerful than any other previously discovered multi-potent stem cells due to their “immune educating abilities”. CB-SCs have the capability to restore autoimmunity and completely eliminate the requirement for stem cell genetic matching because of their low immunogenicity.

Using this new discovery, the Stem Cell Educator was invented to harness the immune modulating power of the CB-SCs for clinical application.

Stem Cell Educator Therapy is the only technology in the world that is licensed to use this stem cell. Educator Therapy does NOT use other stem cells like embryonic stem cells, iPSCs, MSCs, or HSCs.

Insulin injections are not a cure. They only treat the surface symptoms of diabetes. Stem Cell Educator Therapy aims to fundamentally correct the autoimmune destruction of islet beta cells and improve the beta cell function. 

Clinical trials reveal that a single treatment of Educator Therapy can provide a lasting reversal of autoimmunity that allows regeneration of islet beta cells and improvement of metabolic control in people with type 1 (T1D) and type 2 (T2D) diabetes. Even long standing participants with over 20 years of type 1 diabetes have demonstrated increased C-peptides, improved sugar control, and regenerated beta cells post treatment. Similar clinical data were achieved in long-standing (> 25 years) severe type 2 diabetic patients, with markedly improving islet beta-cell function after receiving one treatment with Educator therapy.

Multi-center clinical trials in the United States, China, and Spain have demonstrated the safety and efficacy of Educator Therapy in more than 200 participants (including T1D and T2D) spanning from 3 - 70 years old. In follow up studies, more than 70% of participants who underwent Educator Therapy showed significant, statistical improvement in their immune markers. This improvement was demonstrated by measuring Tregs, Th1/Th2 cytokines, and autoimmune memory T-cells. Notably, insulin dosages have been reduced or stopped in some patients. 

Alopecia Areata 

Alopecia Areata is a common autoimmune disease that results in loss of body hair in varying degrees. Current immune-suppressant treatments such as JAK inhibitors can only temporarily subdue the effects of alopecia areata. A cessation of the medication will result in a 100% relapse.

Clinical studies have demonstrated Stem Cell Educator Therapy’s ability to establish systemic immune modulation and produce significant and/or complete hair regrowth by restoring the immune privilege of hair follicles. Additionally, Educator Therapy modifies rather than destroys the cells responsible for autoimmune responses, without increasing the chances of infection and tumor formation as demonstrated by long-term follow-up studies (four years post treatment). Severe patients with alopecia areata have demonstrated significant, sustained hair regrowth within 3-6 months of treatment.

 COVID-19

COVID-19 has proved fatal to countless people with a compromised immune system. Similar to the principle mechanisms in treating autoimmune diseases, Stem Cell Educator Therapy aims to reset and strengthen the compromised immune systems and thereby reducing the high mortality rate among severe COVID-19 patients.

The infection of SARS-CoV-2 virus behind the COVID-19 pandemic involves multiple immune cells including T cells, B cells, monocytes, and macrophages. Conveniently, Stem Cell Educator Therapy has demonstrated its ability to correct multiple immune dysfunctions among these immune cells. In light of this, the new clinical trial will prove very effective in correcting the systemic inflammatory responses and their functional defects among COVID-19 patients.

Educator Therapy has been tested in the United States, China and Spain only on limited types of autoimmune diseases so far. The clinical data of these and other pilot trials have successfully demonstrated the principle mechanism of Stem Cell Educator Therapy—Immune Education. We aim to expand our research to other autoimmune diseases and beyond.

Unrivaled Innovation

No stem cell injections

Stem Cell Educator Therapy utilizes an ex-vivo method, ensuring immune acceptance and eliminating risks of rejection. Stem cells are permanently contained in the Stem Cell Educator Device, ensuring no foreign cells enter the patient’s body.

No stem cells from animals or aborted fetuses

Many stem cell therapies use stem cells from animals and aborted fetuses which can result in safety risks, ethical and religious concerns. Stem Cell Educator Therapy eliminates these issues and thereby opens many markets traditionally closed to stem cell therapies.

Safety

Stem Cell Educator Therapy is a minimally invasive treatment that takes place outside of one’s body. Clinical trials demonstrate this therapy has minimal to negligible side effects.

Proven Research

Over 15 years of research and more than 200 clinical trial subjects from around the world demonstrate the safety and efficacy of Stem Cell Educator Therapy.

World's only CB-SC stem cell technology

Stem Cell Educator Therapy is the only technology in the world that uses the CB-SC which is more powerful than any other stem cell in its immune-modulating abilities. They have the capability to correct autoimmunity, restore immune balance, and eliminate the requirement for stem cell genetic matching.

Unlimited expansion of technology

Stem Cell Educator Therapy has unlimited application potential. Clinical evidence already demonstrates its efficacy for diabetes, alopecia, and other autoimmune diseases. Continued research aims to demonstrate its efficacy in other rare and incurable diseases.